| Issue | Title | |
| Vol 1, Issue 1 (2021) | Pharmacogenetics of quetiapine | Abstract PDF (Eng) |
| A. K. Abdyrakhmanova, N. A. Shnayder, N. G. Neznanov, R. F. Nasyrova | ||
| Vol 2, Issue 1 (2022) | Phase I of Antipsychotics Metabolism and its Pharmacogenetic Testing | Abstract PDF (Eng) |
| N. A. Shnayder, A. K. Abdyrakhmanova, R. F. Nasyrova | ||
| Vol 3, Issue 2 (2023) | Phenocopy of Amyotrophic Lateral Sclerosis in Patients with Chiari 1 Malformation Associated Syringomyelia: Brief Literature Review | Abstract PDF (Eng) |
| M. Al-Zamil, N. G. Kulikova | ||
| Vol 1, Issue 2 (2021) | Possibilities and limitations of antidepressant use to correct depressive and negative symptoms in schizophrenia | Abstract PDF (Eng) |
| M. A. Novitsky, A. De Sousa, A. R. Asadullin, O. A. Gavrilyuk, A. V. Petrov, R. F. Nasyrova | ||
| Vol 4, Issue 4 (2024) | Possibilities of Analyzing the Speech of Patients with Mental Disorders Using Mathematical Methods and Artificial Intelligence Algorithms | Abstract PDF (Eng) |
| M. A. Barulina, N. V. Zakharova, R. F. Nasyrova, D. M. Ivashinenko, M. A. Dvoryankina, A. I. Rakhmatullin | ||
| Vol 5, Issue 2 (2025) | Prediction of Congenital Malformations in The Fetus Based on The Carriage of Single Nucleotide Variants of Folate Cycle Genes by a Mother with Epilepsy | Abstract PDF (Eng) |
| Albina V. Yakunina, Anastasiya S. Chesnokova, Natalia N. Savelieva | ||
| Vol 4, Issue 1 (2024) | Predictive Pharmacogenetic Testing in Psychiatry: Pros and Cons | Abstract PDF (Eng) |
| A. Yu. Avilov, A. V. Kidyaeva, E. E. Vaiman | ||
| Vol 1, Issue 2 (2021) | Prevalence of non-motor disorders in Parkinson`s disease | Abstract PDF (Eng) |
| N. Yu. Safonova, M. R. Sapronova, O A. Gavrilyuk, T. E. Popova, A. A. Tappakhov | ||
| Vol 1, Issue 2 (2021) | Prospects for studying the pharmacokinetics, pharmacodynamics and pharmacogenetics of vitamin C in patients with neurological diseases and mental disorders | Abstract PDF (Eng) |
| P. S. Goncharova, T. K. Davydova, N. G. Zhukova | ||
| Vol 1, Issue 1 (2021) | Relations of CYP2C19*2 genetic polymorphisms to plasma and saliva concentrations of diazepam in patients hospitalized for alcohol withdrawal | Abstract PDF (Eng) |
| V. Yu. Skryabin, M. S. Zastrozhin, E. A. Grishina, K. A. Ryzhikova, V. V. Shipitsyn, T. E. Galaktionova, E. A. Bryun, D. A. Sychev | ||
| 91 - 100 of 123 Items | << < 5 6 7 8 9 10 11 12 13 > >> | |
Browse Title Index
Popular articles
Vol 2, Issue 1 (2022)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Vol 1, Issue 1 (2021)
Keywords
Alzheimer's disease
Parkinson's disease
adverse reaction
antipsychotic
antipsychotics
anxiety
biomarkers
candidate genes
efficacy
epilepsy
genetics
long QT syndrome
metabolic syndrome
personalized medicine
pharmacogenetic testing
pharmacogenetics
safety
schizophrenia
single nucleotide variant
therapeutic resistance
treatment
3, Bekhterev street, bldg. 6, 192019, Saint-Petersburg, Russian Federation
Telephone: +7 (812) 670 02 20, add. 7813, 7814
E-mail: journal.ppnn@gmail.com
